Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINE1 | P05121 | 4/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.32 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.32 |
| ▸ | DHODH | Q02127 | 1/20 | 0.31 |
| ▸ | DNMT1 | P26358 | 3/20 | 0.31 |
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
| ▸ | RXRB | P28702 | 1/20 | 0.30 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.30 |
| ▸ | WEE1 | P30291 | 1/20 | 0.30 |
| ▸ | KIF11 | P52732 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24601598 | 0.95 | SERPINE1 (0.38) | SERPINE1GPR84CYP19A1HSD17B2DHODH | |
| SCHEMBL24601567 | 0.95 | SERPINE1 (0.37) | SERPINE1GPR84CYP19A1HSD17B2DHODH | |
| SCHEMBL24601591 | 0.94 | SERPINE1 (0.37) | SERPINE1GPR84CYP19A1HSD17B2DHODH | |
| SCHEMBL24601566 | 0.93 | SERPINE1 (0.33) | SERPINE1GPR84DNMT1CHEK1WEE1 | |
| SCHEMBL24601801 | 0.93 | GPR84 (0.37) | SERPINE1GPR84CYP19A1HSD17B2DHODH | |
| SCHEMBL24601800 | 0.92 | GPR84 (0.37) | SERPINE1GPR84HSD17B2DHODHKIF11 | |
| SCHEMBL24601482 | 0.91 | SERPINE1 (0.34) | SERPINE1GPR84DNMT1RXRARXRB | |
| SCHEMBL24601645 | 0.89 | GPR84 (0.34) | SERPINE1GPR84DNMT1RXRARXRB | |
| SCHEMBL24601560 | 0.88 | SERPINE1 (0.35) | SERPINE1GPR84CYP19A1DNMT1CHEK1 | |
| SCHEMBL24601563 | 0.88 | GPR84 (0.34) | SERPINE1GPR84DNMT1RXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220213113-A1 | NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220213113-A1 | NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | NCL, NOC2L, NOLC1 | SERPINE1 4819/4885GPR84 4574/4885CYP19A1 4125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.